Sign In

25.3 : Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released upon insulin binding, leading to autophosphorylation and transphosphorylation of the β subunits. This initiates signaling by phosphorylating intracellular proteins like IRSs and Shc protein, which interact with effectors, extending the signaling cascade.

Insulin's action on glucose transport depends on PI3K activation, which interacts with IRS proteins to generate PIP3, regulating downstream kinases' localization and activity. Akt2 isoform controls essential downstream steps for glucose uptake in skeletal muscle and adipose tissue and regulates glucose production in the liver.

Following insulin receptor activation, GLUT4, predominantly expressed in insulin-responsive tissues, translocates rapidly to the plasma membrane, facilitating inward glucose transport. Insulin signaling also decreases GLUT4 endocytosis, increasing its plasma membrane residence time. Once inside cells, glucose is phosphorylated to G6P by hexokinases and can be stored as glycogen or enter the glycolytic or pentose phosphate pathways.

From Chapter 25:

article

Now Playing

25.3 : Insulin: The Receptor and Signaling Pathways

Insulin and Hypoglycemic Drugs

85 Views

article

25.1 : Glucose Homeostasis: Regulation of Blood Glucose

Insulin and Hypoglycemic Drugs

66 Views

article

25.2 : Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

Insulin and Hypoglycemic Drugs

49 Views

article

25.4 : Pathophysiology of Diabetes

Insulin and Hypoglycemic Drugs

205 Views

article

25.5 : Diabetes: Symptoms, Diagnosis, and Complications

Insulin and Hypoglycemic Drugs

125 Views

article

25.6 : Diabetes: Management and Pharmacotherapy

Insulin and Hypoglycemic Drugs

20 Views

article

25.7 : Insulin: Biosynthesis, Chemistry, and Preparation

Insulin and Hypoglycemic Drugs

44 Views

article

25.8 : Insulin Formulations: Types and Delivery

Insulin and Hypoglycemic Drugs

19 Views

article

25.9 : Insulin: Dosing Regimen and Adverse Effects

Insulin and Hypoglycemic Drugs

15 Views

article

25.10 : Oral Hypoglycemic Agents: Sulfonylureas

Insulin and Hypoglycemic Drugs

18 Views

article

25.11 : Oral Hypoglycemic Agents: Biguanides and Glitazones

Insulin and Hypoglycemic Drugs

22 Views

article

25.12 : Oral Hypoglycemic Agents: Glinides

Insulin and Hypoglycemic Drugs

17 Views

article

25.13 : Oral Hypoglycemic Agents: α-Glucosidase Inhibitors

Insulin and Hypoglycemic Drugs

18 Views

article

25.14 : Glucagon-like Receptor Agonists

Insulin and Hypoglycemic Drugs

27 Views

article

25.15 : Dipeptidyl Peptidase 4 Inhibitors

Insulin and Hypoglycemic Drugs

14 Views

See More

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2025 MyJoVE Corporation. All rights reserved